Peripherally induced tolerance depends on peripheral regulatory T cells that require hopx to inhibit intrinsic IL-2 expression

Journal of Immunology

Volumn 195, Issue 4, 2015, Pages 1489-1497

  Jones, Andrew ^a   Opejin, Adeleye ^a   Henderson, Jacob G ^a   Gross, Cindy ^a   Jain, Rajan ^b   Epstein, Jonathan A ^b   Flavell, Richard A ^c   Hawiger, Daniel ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CELL PROTEIN; HOMEODOMAIN ONLY PROTEIN; INTERLEUKIN 2; UNCLASSIFIED DRUG; HOD PROTEIN, MOUSE; HOMEODOMAIN PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ASSAY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE FUNCTION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; ANIMAL; AUTOIMMUNITY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; AUTOANTIGENS; AUTOIMMUNITY; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HOMEODOMAIN PROTEINS; IMMUNE TOLERANCE; INFLAMMATION; INTERLEUKIN-2; MICE; MICE, KNOCKOUT; T-LYMPHOCYTES, REGULATORY;

EID: 84938912403     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500174     Document Type: Article

References (71)

1. Mathis, D., and C. Benoist. 2009. Aire. Annu. Rev. Immunol. 27: 287-312.
2. Curotto de Lafaille, M.A., and J. J. Lafaille. 2009. Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 30: 626-635.
3. Belkaid, Y., and K. Tarbell. 2009. Regulatory T cells in the control of hostmicroorganism interactions (∗). Annu. Rev. Immunol. 27: 551-589.
4. von Boehmer, H., and F. Melchers. 2010. Checkpoints in lymphocyte development and autoimmune disease. Nat. Immunol. 11: 14-20.
5. Bilate, A. M., and J. J. Lafaille. 2012. Induced CD4+Foxp3+ regulatory T cells in immune tolerance. Annu. Rev. Immunol. 30: 733-758.
6. Josefowicz, S. Z., L. F. Lu, and A. Y. Rudensky. 2012. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30: 531-564.
7. Sakaguchi, S., D. A. Vignali, A. Y. Rudensky, R. E. Niec, and H. Waldmann. 2013. The plasticity and stability of regulatory T cells. Nat. Rev. Immunol. 13: 461-467.
8. Bollrath, J., and F. M. Powrie. 2013. Controlling the frontier: regulatory T-cells and intestinal homeostasis. Semin. Immunol. 25: 352-357.
9. Miller, S. D., R. P. Wetzig, and H. N. Claman. 1979. The induction of cellmediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells. J. Exp. Med. 149: 758-773.
10. Critchfield, J. M., M. K. Racke, J. C. Zúñiga-Pflücker, B. Cannella, C. S. Raine, J. Goverman, and M. J. Lenardo. 1994. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 263: 1139-1143.
11. Smilek, D. E., A. M. Gautam, C. Pearson, L. Steinman, and H. O. McDevitt. 1992. EAE: a model for immune intervention with synthetic peptides. Int. Rev. Immunol. 9: 223-230.
12. Whitham, R. H., B. L. Kotzin, A. C. Buenafe, A. D. Weinberg, R. E. Jones, G. A. Hashim, C. M. Hoy, A. A. Vandenbark, and H. Offner. 1993. Treatment of relapsing experimental autoimmune encephalomyelitis with T cell receptor peptides. J. Neurosci. Res. 35: 115-128.
13. Turley, D. M., and S. D. Miller. 2007. Peripheral tolerance induction using ethylenecarbodiimide-fixed APCs uses both direct and indirect mechanisms of antigen presentation for prevention of experimental autoimmune encephalomyelitis. J. Immunol. 178: 2212-2220.
14. Wasserman, H. A., and B. D. Evavold. 2008. Induction of anergy by antibody blockade of TCR in myelin oligodendrocyte glycoprotein-specific cells. J. Immunol. 180: 7259-7264.
15. Getts, D. R., D. M. Turley, C. E. Smith, C. T. Harp, D. McCarthy, E. M. Feeney, M. T. Getts, A. J. Martin, X. Luo, R. L. Terry, et al. 2011. Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells. J. Immunol. 187: 2405-2417.
16. Zhang, H., J. R. Podojil, J. Chang, X. Luo, and S. D. Miller. 2010. TGF-betainduced myelin peptide-specific regulatory T cells mediate antigen-specific suppression of induction of experimental autoimmune encephalomyelitis. J. Immunol. 184: 6629-6636.
17. Getts, D. R., A. J. Martin, D. P. McCarthy, R. L. Terry, Z. N. Hunter, W. T. Yap, M. T. Getts, M. Pleiss, X. Luo, N. J. King, et al. 2012. Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis. Nat. Biotechnol. 30: 1217-1224.
18. Darrasse-Jèze, G., S. Deroubaix, H. Mouquet, G. D. Victora, T. Eisenreich, K. H. Yao, R. F. Masilamani, M. L. Dustin, A. Rudensky, K. Liu, and M. C. Nussenzweig. 2009. Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J. Exp. Med. 206: 1853-1862.
19. Kretschmer, K., I. Apostolou, D. Hawiger, K. Khazaie, M. C. Nussenzweig, and H. von Boehmer. 2005. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6: 1219-1227.
20. Yogev, N., F. Frommer, D. Lukas, K. Kautz-Neu, K. Karram, D. Ielo, E. von Stebut, H. C. Probst, M. van den Broek, D. Riethmacher, et al. 2012. Dendritic cells ameliorate autoimmunity in the CNS by controlling the homeostasis of PD-1 receptor(+) regulatory T cells. Immunity 37: 264-275.
21. Idoyaga, J., C. Fiorese, L. Zbytnuik, A. Lubkin, J. Miller, B. Malissen, D. Mucida, M. Merad, and R. M. Steinman. 2013. Specialized role of migratory dendritic cells in peripheral tolerance induction. J. Clin. Invest. 123: 844-854.
22. Stern, J. N., D. B. Keskin, Z. Kato, H. Waldner, S. Schallenberg, A. Anderson, H. von Boehmer, K. Kretschmer, and J. L. Strominger. 2010. Promoting tolerance to proteolipid protein-induced experimental autoimmune encephalomyelitis through targeting dendritic cells. Proc. Natl. Acad. Sci. USA 107: 17280-17285.
23. Ring, S., M. Maas, D. M. Nettelbeck, A. H. Enk, and K. Mahnke. 2013. Targeting of autoantigens to DEC205+ dendritic cells in vivo suppresses experimental allergic encephalomyelitis in mice. J. Immunol. 191: 2938-2947.
24. Mascanfroni, I. D., A. Yeste, S. M. Vieira, E. J. Burns, B. Patel, I. Sloma, Y. Wu, L. Mayo, R. Ben-Hamo, S. Efroni, et al. 2013. IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39. Nat. Immunol. 14: 1054-1063.
25. Manicassamy, S., and B. Pulendran. 2011. Dendritic cell control of tolerogenic responses. Immunol. Rev. 241: 206-227.
26. Satpathy, A. T., X. Wu, J. C. Albring, and K. M. Murphy. 2012. Re(de)fining the dendritic cell lineage. Nat. Immunol. 13: 1145-1154.
27. Merad, M., P. Sathe, J. Helft, J. Miller, and A. Mortha. 2013. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu. Rev. Immunol. 31: 563-604.
28. Hawiger, D., R. F. Masilamani, E. Bettelli, V. K. Kuchroo, and M. C. Nussenzweig. 2004. Immunological unresponsiveness characterized by increased expression of CD5 on peripheral T cells induced by dendritic cells in vivo. Immunity 20: 695-705.
29. Hawiger, D., Y. Y. Wan, E. E. Eynon, and R. A. Flavell. 2010. The transcription cofactor Hopx is required for regulatory T cell function in dendritic cellmediated peripheral T cell unresponsiveness. Nat. Immunol. 11: 962-968.
30. Shin, C. H., Z. P. Liu, R. Passier, C. L. Zhang, D. Z. Wang, T. M. Harris, H. Yamagishi, J. A. Richardson, G. Childs, and E. N. Olson. 2002. Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. Cell 110: 725-735.
31. Wan, Y. Y., and R. A. Flavell. 2005. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl. Acad. Sci. USA 102: 5126-5131.
32. Bettelli, E., M. Pagany, H. L. Weiner, C. Linington, R. A. Sobel, and V. K. Kuchroo. 2003. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197: 1073-1081.
33. Schorle, H., T. Holtschke, T. Hünig, A. Schimpl, and I. Horak. 1991. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352: 621-624.
34. Takeda, N., R. Jain, M. R. Leboeuf, A. Padmanabhan, Q. Wang, L. Li, M. M. Lu, S. E. Millar, and J. A. Epstein. 2013. Hopx expression defines a subset of multipotent hair follicle stem cells and a progenitor population primed to give rise to K6+ niche cells. Development 140: 1655-1664.
35. Hawiger, D., K. Inaba, Y. Dorsett, M. Guo, K. Mahnke, M. Rivera, J. V. Ravetch, R. M. Steinman, and M. C. Nussenzweig. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194: 769-779.
36. Steinman, R. M., D. Hawiger, and M. C. Nussenzweig. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21: 685-711.
37. Bonifaz, L., D. Bonnyay, K. Mahnke, M. Rivera, M. C. Nussenzweig, and R. M. Steinman. 2002. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 196: 1627-1638.
38. Yamazaki, S., D. Dudziak, G. F. Heidkamp, C. Fiorese, A. J. Bonito, K. Inaba, M. C. Nussenzweig, and R. M. Steinman. 2008. CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells. J. Immunol. 181: 6923-6933.
39. Viglietta, V., C. Baecher-Allan, H. L. Weiner, and D. A. Hafler. 2004. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199: 971-979.
40. Wu, Y., M. Borde, V. Heissmeyer, M. Feuerer, A. D. Lapan, J. C. Stroud, D. L. Bates, L. Guo, A. Han, S. F. Ziegler, et al. 2006. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126: 375-387.
41. Malek, T. R., and I. Castro. 2010. Interleukin-2 receptor signaling: at the interface between tolerance and immunity. Immunity 33: 153-165.
42. Chen, F., H. Kook, R. Milewski, A. D. Gitler, M. M. Lu, J. Li, R. Nazarian, R. Schnepp, K. Jen, C. Biben, et al. 2002. Hop is an unusual homeobox gene that modulates cardiac development. Cell 110: 713-723.
43. Davidson, T. S., R. J. DiPaolo, J. Andersson, and E. M. Shevach. 2007. Cutting Edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells. J. Immunol. 178: 4022-4026.
44. Curotto de Lafaille, M. A., N. Kutchukhidze, S. Shen, Y. Ding, H. Yee, and J. J. Lafaille. 2008. Adaptive Foxp3+ regulatory T cell-dependent and-independent control of allergic inflammation. Immunity 29: 114-126.
45. Josefowicz, S. Z., R. E. Niec, H. Y. Kim, P. Treuting, T. Chinen, Y. Zheng, D. T. Umetsu, and A. Y. Rudensky. 2012. Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 482: 395-399.
46. Samstein, R. M., S. Z. Josefowicz, A. Arvey, P. M. Treuting, and A. Y. Rudensky. 2012. Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell 150: 29-38.
47. Lathrop, S. K., S. M. Bloom, S. M. Rao, K. Nutsch, C. W. Lio, N. Santacruz, D. A. Peterson, T. S. Stappenbeck, and C. S. Hsieh. 2011. Peripheral education of the immune system by colonic commensal microbiota. Nature 478: 250-254.
48. Korn, T., J. Reddy, W. Gao, E. Bettelli, A. Awasthi, T. R. Petersen, B. T. Bäckström, R. A. Sobel, K. W. Wucherpfennig, T. B. Strom, et al. 2007. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13: 423-431.
49. Bailey-Bucktrout, S. L., M. Martinez-Llordella, X. Zhou, B. Anthony, W. Rosenthal, H. Luche, H. J. Fehling, and J. A. Bluestone. 2013. Self-antigendriven activation induces instability of regulatory T cells during an inflammatory autoimmune response. Immunity 39: 949-962.
50. Zhou, X., S. L. Bailey-Bucktrout, L. T. Jeker, C. Penaranda, M. Mart?nez-Llordella, M. Ashby, M. Nakayama, W. Rosenthal, and J. A. Bluestone. 2009. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10: 1000-1007.
51. Kee, H. J., J. R. Kim, K. I. Nam, H. Y. Park, S. Shin, J. C. Kim, Y. Shimono, M. Takahashi, M. H. Jeong, N. Kim, et al. 2007. Enhancer of polycomb1, a novel homeodomain only protein-binding partner, induces skeletal muscle differentiation. J. Biol. Chem. 282: 7700-7709.
52. Hamamori, Y., and M. D. Schneider. 2003. HATs off to Hop: recruitment of a class I histone deacetylase incriminates a novel transcriptional pathway that opposes cardiac hypertrophy. J. Clin. Invest. 112: 824-826.
53. Kook, H., J. J. Lepore, A. D. Gitler, M. M. Lu, W. Wing-Man Yung, J. Mackay, R. Zhou, V. Ferrari, P. Gruber, and J. A. Epstein. 2003. Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop. J. Clin. Invest. 112: 863-871.
54. Kook, H., W. W. Yung, R. J. Simpson, H. J. Kee, S. Shin, J. A. Lowry, F. E. Loughlin, Z. Yin, J. A. Epstein, and J. P. Mackay. 2006. Analysis of the structure and function of the transcriptional coregulator HOP. Biochemistry 45: 10584-10590.
55. Yin, Z., L. Gonzales, V. Kolla, N. Rath, Y. Zhang, M. M. Lu, S. Kimura, P. L. Ballard, M. F. Beers, J. A. Epstein, and E. E. Morrisey. 2006. Hop functions downstream of Nkx2.1 and GATA6 to mediate HDAC-dependent negative regulation of pulmonary gene expression. Am. J. Physiol. Lung Cell. Mol. Physiol. 291: L191-L199.
56. Takeda, N., R. Jain, M. R. LeBoeuf, Q. Wang, M. M. Lu, and J. A. Epstein. 2011. Interconversion between intestinal stem cell populations in distinct niches. Science 334: 1420-1424.
57. Katoh, H., K. Yamashita, M. Waraya, O. Margalit, A. Ooki, H. Tamaki, H. Sakagami, K. Kokubo, D. Sidransky, and M. Watanabe. 2012. Epigenetic silencing of HOPX promotes cancer progression in colorectal cancer. Neoplasia 14: 559-571.
58. Cheung, W. K., M. Zhao, Z. Liu, L. E. Stevens, P. D. Cao, J. E. Fang, T. F. Westbrook, and D. X. Nguyen. 2013. Control of alveolar differentiation by the lineage transcription factors GATA6 and HOPX inhibits lung adenocarcinoma metastasis. Cancer Cell 23: 725-738.
59. Watanabe, H., and M. Meyerson. 2013. Hopping between differentiation states in lung adenocarcinoma. Cancer Cell 23: 707-709.
60. Albrecht, I., U. Niesner, M. Janke, A. Menning, C. Loddenkemper, A. A. Kühl, I. Lepenies, M. H. Lexberg, K. Westendorf, K. Hradilkova, et al. 2010. Persistence of effector memory Th1 cells is regulated by Hopx. Eur. J. Immunol. 40: 2993-3006.
61. Yamaguchi, T., A. Kishi, M. Osaki, H. Morikawa, P. Prieto-Martin, K. Wing, T. Saito, and S. Sakaguchi. 2013. Construction of self-recognizing regulatory T cells from conventional T cells by controlling CTLA-4 and IL-2 expression. Proc. Natl. Acad. Sci. USA 110: E2116-E2125.
62. Baine, I., S. Basu, R. Ames, R. S. Sellers, and F. Macian. 2013. Helios induces epigenetic silencing of IL2 gene expression in regulatory T cells. J. Immunol. 190: 1008-1016.
63. Thornton, A. M., and E. M. Shevach. 1998. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188: 287-296.
64. Liao, W., J. X. Lin, and W. J. Leonard. 2013. Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Immunity 38: 13-25.
65. Boyman, O., M. Kovar, M. P. Rubinstein, C. D. Surh, and J. Sprent. 2006. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 311: 1924-1927.
66. Tang, Q., J. Y. Adams, C. Penaranda, K. Melli, E. Piaggio, E. Sgouroudis, C. A. Piccirillo, B. L. Salomon, and J. A. Bluestone. 2008. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28: 687-697.
67. Webster, K. E., S. Walters, R. E. Kohler, T. Mrkvan, O. Boyman, C. D. Surh, S. T. Grey, and J. Sprent. 2009. In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J. Exp. Med. 206: 751-760.
68. Grigorian, A., H. Mkhikian, and M. Demetriou. 2012. Interleukin-2, Interleukin-7, T cell-mediated autoimmunity, and N-glycosylation. Ann. N. Y. Acad. Sci. 1253: 49-57.
69. Kim, M. G., T. Y. Koo, J. J. Yan, E. Lee, K. H. Han, J. C. Jeong, H. Ro, B. S. Kim, S. K. Jo, K. H. Oh, et al. 2013. IL-2/anti-IL-2 complex attenuates renal ischemia-reperfusion injury through expansion of regulatory T cells. J. Am. Soc. Nephrol. 24: 1529-1536.
70. Pierson, W., B. Cauwe, A. Policheni, S. M. Schlenner, D. Franckaert, J. Berges, S. Humblet-Baron, S. Schönefeldt, M. J. Herold, D. Hildeman, et al. 2013. Antiapoptotic Mcl-1 is critical for the survival and niche-filling capacity of Foxp3+ regulatory T cells. Nat. Immunol. 14: 959-965.
71. Carbone, F., V. De Rosa, P. B. Carrieri, S. Montella, D. Bruzzese, A. Porcellini, C. Procaccini, A. La Cava, and G. Matarese. 2014. Regulatory T cell proliferative potential is impaired in human autoimmune disease. Nat. Med. 20: 69-74.